Here’s why the FTSE 100 is a great place to invest for 2018 and beyond

Even through turbulent times, the FTSE 100 (INDEXFTSE:UKX) is likely to beat other investments hands down.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As I write, the week before Christmas, the FTSE 100 is up around 6% since the start of 2017. 

Now, you might not be too impressed by that after 2016’s performance, with London’s top index now up a cracking 25% over the two years. But the boom following 2016’s Brexit referendum is a bit misleading due to the crash in the value of the pound — while the value of shares in pounds has risen strongly, those pounds are worth considerably less now.

And this year’s 6% is actually pretty good, especially when you can add on about another 3% in dividends — 9% per year would be a superb long-term average, and would turn £1,000 into nearly £2,400 in 10 years.

Over a rocky five years, the FTSE 100 is up around 25% (plus dividends), and again that’s a great performance which could make you very wealthy over a lifetime.

Biggest did best

But after examining the index overall, I started to look at some of its biggest companies, and the results are very interesting. Starting with the current 10 biggest stocks by market capitalisation, I checked their five-year performances. I won’t list them all, but the biggest of the lot, Royal Dutch Shell, brought in a 10% return (during the oil crisis), while the one in 10th place, Unilever, put on a whopping 75% for the biggest gain. 

GlaxoSmithKline was the poorest performer with a 5% fall, but sector compatriot AstraZeneca gained 62%, with British American Tobacco just behind on 59%.

But get this — the total share price return from the 10 biggest stocks over five years came to 33%, beating the FTSE 100’s overall 25%. And in their last full year, the average dividend yield from these biggest companies came to 4.6%, which is well ahead of the index.

Top dividends

That made me wonder how the current 10 biggest dividend-paying stocks have done over the same period. So I selected the 10 with the biggest prospective total dividend yields (which are mostly expectations for the 2017 full year) and examined the past five years again — and the results took me by surprise.

Of course, the average prospective dividend yield is higher, at 6.6% — and that, reinvested and compounded over the long term, would result in a very nice overall return even without any capital appreciation.

But the big shock for me is that the top 10 dividend stocks provided the best capital gains too. The range was considerably more volatile, with Centrica shares losing 41% over five years, but housebuilders came good with both Taylor Wimpey and Barratt Developments more than trebling in price.

The overall share price gain? A cracking 48%, which knocks spots off both the 10 biggest and the overall FTSE 100.

Beating the FTSE

Now, this does not represent proper back-testing, which would require far more digging into past data. But I do find the outcome intriguing.

The biggest companies tend to be the ones that have been there for years, and are stable in their annual profits, so you’re avoiding the riskier smaller constituents which are more likely to lower the FTSE 100’s overall returns.

And the FTSE 100 high-yield strategy is a very popular one, especially with investors looking for steady income — but it just might surprise you how good its capital appreciation can be.

There will be some ups and downs for sure, but I can think of worse ways to invest in 2018.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca and Royal Dutch Shell. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£9,000 in savings? Here’s how to try and turn that into a £193 monthly second income

With a long-term approach and applying basic principles of good investment, our writer reckons someone with under £10k could earn…

Read more »

Investing Articles

A 2026 stock market crash could be a rare passive income opportunity

If a stock market crash comes our way then it might throw up plentiful opportunities for investors to secure a…

Read more »

Tesla car at super charger station
Investing Articles

£10,000 invested in Tesla stock 1 year ago is now worth…

Dr James Fox takes a closer look at Tesla stock with the incredibly volatile mega-cap company surging and pulling back…

Read more »

British pound data
Investing Articles

My personal warning for anyone tempted by the plunging Aston Martin share price

Harvey Jones was so captivated by the plunging Aston Martin share price that he ignored an old piece of investment…

Read more »

Stacks of coins
Investing Articles

This penny share just crashed 13% to 19p! Time to buy?

After another fall today, this penny stock has now crashed 70% since April 2021. Is it one that should be…

Read more »

Trader on video call from his home office
Investing Articles

Down 19%! Here’s why Barclays shares look a serious bargain to me right now

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Why Meta Platforms shares fell 12.5% in March

Historically, investors have done well by buying Meta Platforms shares when the price has fallen. But is the latest legal…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£20,000 invested in BAE Systems shares 4 years ago is now worth…

BAE Systems' shares have soared since 2022, yet rising NATO budgets are just starting to feed through, so the real…

Read more »